Home More Information about I-SPY 2 Participating Cancer Centers Peer Support for I-SPY 2 Participants More Information About Breast Cancer I-SPY 2 Breast.

Slides:

Advertisements

Similar presentations

Draft -- September, Randomize Agree? Make Patients Aware of Trial Enroll & Start Treatment Screening Consent Discussion Interest ? Eligible? Agree?

Advertisements

Clinical Trials What Are They and When Are They Right For You? Maura N. Dickler Assistant Attending Physician Breast Cancer Medicine Service Memorial Sloan-Kettering.

Ask Me Anything American Nurses Training Association.

DIAN Treatment Trials An Update Sunday February 10, :00 to 6:00 PM CST Presented by Randall Bateman MD DIAN Therapeutic Trials Unit Director DIAN.

SUTENT  (sunitinib malate) capsules Access Slide Kit.

Research Protocol ACRIN 6678 Learning About PET/CT Scans: Can PET/CT scans provide helpful information for the treatment of non-small cell lung cancer?

Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.

What to do if you have an injury or illness that is not related to work. Click on left side of mouse to advance to next slide.

HIV Clinical Trials Janice Price, M.Ed, RN HIV Clinical Research Program Coordinator Swedish Medical Center Seattle, WA USA.

Consent for Research Study A Study for Women with Advanced Cervical Cancer: Learning whether an MRI scan with an investigative contrast agent (called.

Clinical Perspective. Screening/Prevention Who is at risk for what type Decision to Intervene: Risk Assessment normal Evidence of Disease Disability Death.

Developing information for participants in your research -Making your first draft This presentation will help you to create the first draft of your participant.

Putnam County Hospital CANCER CENTER The Cancer Center is located on the 2 nd floor of Putnam County Hospital. Continuously Accredited by the American.

Breast cancer and medical second opinion

Cancer Clinical Trials: The Way We Make Progress Against Cancer.

Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery

Myths and Facts About Cancer Clinical Trials. Copyright ENACCT, 2007 It’s a treatment of “last resort!” They treat you like a “guinea pig ” No one benefits.

How You Can Be an Advocate for Clinical Trials in Your Community.

(Sample only—revise language or content to reflect the understanding and circumstances of the person signing.) POWER OF ATTORNEY FOR MEDICAL TREATMENT.

What to Expect When a Lump Is Detected

The Hartford’s Texas Workers’ Compensation Health Care Network.

Ductal Carcinoma in situ

ACRIN 6657/CALGB Consent for Research Study Contrast-Enhanced Breast MRI and MRS: A Correlative Science Studies to Characterize Tumor Response in.

D etection of E arly Lung C ancer A mong M ilitary P ersonnel Study 1 Version

April  Ensure all counselors are familiar with the pros and cons of participation in clinical trials  Ensure all counselors are familiar with.

Bursledon Surgery FLU SEASON If you are 65 years or older, have a chronic disease like heart disease, diabetes or have a respiratory or an auto immune.

How to Find and Access Clinical Trials New Treatments, No Tricks A Seminar on Minority Participation in Clinical Trials June 15, 2010.

ACRIN 6698 Diffusion-weighted MRI Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: An I-SPY 2 Trial Substudy Presented by:

Quick Reference Guide Welcome TEST USER Version_NSU_ HELP RETIREMENT MANAGER DEMO FEEDBACK.

Consent for Research Study A study for patients with a diagnosis of liver cancer who are on the waiting list for a liver transplant Comparison of advanced.

Personalize. Empower. Improve. Learn how to earn healthy rewards every step of the way “It pays to know your score!”

ACRIN 6671/GOG 0233 Consent for Research Study A study for Women with Advanced Cervical Cancer: Learning whether a PET/CT scan using an imaging agent called.

Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.

Consent2Share Linking Cohort Discovery to Consent David R Nelson MD Assistant Vice President for Research Professor of Medicine Director, Clinical and.

Powered by Whitstable Medical Practice Annual Patient Survey 2014 / 2015 Thank you to all patients who took the time to complete this survey.

ACRIN 6685 Overview ACRIN 6685 A Multi-center Trial of FDG-PET/CT Staging of Head and Neck Cancer and its Impact on the N0 Neck Surgical Treatment in Head.

1. Why do patients participate in clinical trials? 2. Overview of I-SPY2: Interacting with patients 3. Helping patients decide whether or not to participate.

Consent for Research Study A study for patients diagnosed with locally advanced breast cancer Learning if the imaging agent, [ 18 F] fluorothymidine (FLT),

Informatics in Breast Cancer Research I-SPY 2 TRIAL & TRANSCEND.

Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.

Prelude DS ELND005 for Down Syndrome Information for Participants I would like to tell you what this study is about and then you can decide if you would.

Consent for Research Study A study using 18 F-Fluoride for prostate cancer patients currently enrolled in Dr. Febbo’s “Genomic Guided Therapy” study A.

WHAT DOES MEDICAL HOME MEAN TO YOUR FAMILIES. Medical Care is just part of our lives.

PROTOCOL GO29294 A study evaluating a potential new treatment for locally advanced or metastatic urothelial bladder cancer VERSION 1 | 19 SEPTEMBER 2014.

Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.

Prognostic Value of Genomic Analysis After Neoadjuvant Chemotherapy for Breast Cancer Mayer EL et al. Proc SABCS 2010;Abstract P

WHAT SHOULD I THINK WHEN ASKED TO BE IN A CLINICAL TRIAL? Robert L Page II, PharmD, MSPH Professor University of Colorado Schools of Pharmacy and Medicine.

Upon completion of this lesson, you will be able to: Identify different diagnostic procedures for breast cancer screening Describe different diagnostic.

Rationalizing the New Healthcare Paradigm Scientific Agenda vs. Patient Imperatives Scientific Agenda vs. Patient Imperatives.

Clinical Research and Outcomes Registry Workshop Creating an Informed Consent Form Daniel Ford, MD, MPH Joseph Carrese, MD.

1 Midterm Issues. 2 Social Context Social context is a specific role that a person has in society –E.g. Doctor, lawyer, patient, voter –Not an issue of.

S1207: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients.

UNISON Insert name of Branch here Presented by Insert name of presenter here NMC Revalidation.

Version 3 Sept 2013 What is Colposcopy? Version 3 – Sept 2013 Information Pack for Women with a Learning Disability.

Breast Cancer Treatment. Treatment 2 aspects 1. Treatment of the breast itself: “Local Treatment” 2. Treatment of the whole body = “Systemic treatment”

New research areas in personalised medicines

The Clinical Trial Volunteer’s Bill of Rights

POC Open House Welcome to the POC Open House. My name is _____ and today we will learn about the iPad Courses for the Month of September. If you have any.

Seeing the Doctor Section 3.

Having Breast Cancer Section 7.

MTN-036 Study of Extended Duration Dapivirine Vaginal Ring for HIV Prevention How do I know if I’m Eligible to join? Women who join the study must.

Palliative Care Question Prompt Sheet

Learning About PET/CT Scans:

[Presenter’s Name] [title] [Institution’s name]

Seeing the Doctor Section 3.

Recruitment Video Storyboard Template

Cindy Murray NP Princess Margaret Cancer Centre

Having Breast Cancer Section 7.

[Presenter’s Name] [title] [Institution’s name]

Presentation transcript:

Home More Information about I-SPY 2 Participating Cancer Centers Peer Support for I-SPY 2 Participants More Information About Breast Cancer I-SPY 2 Breast Cancer Clinical Trial Participant Website The I-SPY 2 TRIAL is a clinical trial that is designed to test several investigational drugs for breast cancer. The goal of this trial is to quickly learn which patients are most likely to benefit from these investigational by learning about each patient’s cancer biology and using imaging techniques.

Home More Information about I-SPY 2 Participating Cancer Centers Peer Support for I-SPY 2 Participants More Information About Breast Cancer I-SPY 2 Breast Cancer Clinical Trial Information about I-SPY 2 Commonly Asked Questions about the I-SPY 2 TRIAL How does the I-SPY 2 TRIAL work? What is a biomarker and how are they being used in I-SPY 2? What is a MRI scan and what does it mean to me? What is a core biopsy and what does it mean to me? I nvestigation of S erial studies to S erial studies to Predict Predict Y our Y our T herapeutic R esponse with I maging A nd mo L ecular analysis mo L ecular analysis

Home More Information about I-SPY 2 Participating Cancer Centers Peer Support for I-SPY 2 Participants More Information About Breast Cancer I-SPY 2 Breast Cancer Clinical Trial Information about I-SPY 2 Commonly Asked Questions about the I-SPY 2 TRIAL What happens if I consider joining the I-SPY 2 TRIAL? How do I know if I am eligible for the I-SPY 2 TRIAL? What biomarkers will be used to see if I am eligible for the I-SPY 2 TRIAL? What is MammaPrint ® ? What MammaRrint ® score do I need to participate in I-SPY 2? Why will I receive treatment before surgery in I-SPY 2? Why will I receive 2 different chemotherapy treatments? If I agree to be in I-SPY 2, how soon will I be able to start my treatment? How likely am I to receive an investigational drug if I join I-SPY 2? If I do receive an investigational drug, who pays for the investigational drug, what will it be, and what are the potential short and long term side effects? How many MRIs will I have and how long will each one take? Who will pay for the MRIs that I will have? How many times will tissue be collected, who will pay for the collection, and how will the tissue be collected? How many times will my blood be collected, who will pay for the collection, and how will the blood be collected? What will my tissue and blood samples be used for? Will I be told the results of the tests done from my tissue and blood samples? If I join I-SPY 2, how long will I be in the study? If my cancer does not go away completely after neoadjuvant treatment, what options are available to me for additional treatment? This trial is called I-SPY 2. What was I-SPY 1 and what was learned from it? Whom may I contact if I have additional questions about I-SPY 2?

Home More Information about I-SPY 2 Participating Cancer Centers Peer Support for I-SPY 2 Participants More Information About Breast Cancer I-SPY 2 Breast Cancer Clinical Trial Information about I-SPY 2 TRIAL Commonly Asked Questions about the I-SPY 2 TRIAL What happens if I consider joining the I-SPY 2 TRIAL? How do I know if I am eligible for the I-SPY 2 TRIAL? What biomarkers will be used to see if I am eligible for the I-SPY 2 TRIAL? What is MammaPrint ® ? What MammaRrint ® score do I need to participate in I-SPY 2? Patients that participate in I-SPY 2 are women that we think will likely benefit from chemotherapy. For this trial, your cancer needs to be one of the following to be eligible: 1)MammaPrint High Risk Score 2)MammaPrint Low Risk Score and ER negative 3)MammaPrint Low Risk Score and ER positive and Her2 positive If your cancer does not match one of the above groups, you will not be eligible to join the I-SPY 2 TRIAL. Please discuss other treatment options with your doctor. Why will I receive treatment before surgery in I-SPY 2? Why will I receive 2 different chemotherapy treatments? If I agree to be in I-SPY 2, how soon will I be able to start my treatment? How likely am I to receive an investigational drug if I join I-SPY 2? If I do receive an investigational drug, who pays for the investigational drug, what will it be, and what are the potential short and long term side effects?

Home More Information about I-SPY 2 Participating Cancer Centers Peer Support for I-SPY 2 Participants More Information About Breast Cancer I-SPY 2 Breast Cancer Clinical Trial Cancer Centers Participating in I-SPY 2 Here is a list of Cancer Centers that are enrolling patients in the I-SPY 2 TRIAL: Show Map of US/etc with sites- allow user to click on center’s logo and be directed to their website (either main university site or site’s breast care center site) You can also visit to check your eligibility for I-SPY 2 or other clinical trials in your area.

Home More Information about I-SPY 2 Participating Cancer Centers Peer Support for I-SPY 2 Participants More Information About Breast Cancer I-SPY 2 Breast Cancer Clinical Trial Peer Support for I-SPY 2 Participants A peer support network is available to all I-SPY 2 Participants. Please check with _________ for local services that are available for you. Breast Cancer Network of Strength has a hot-line you can call, , at any time and tell them you would like to speak to an I-SPY 2 counselor. They will take your contact information and arrange to have someone return your call within 48 hours.

Home More Information about I-SPY 2 Participating Cancer Centers Peer Support for I-SPY 2 Participants More Information About Breast Cancer I-SPY 2 Breast Cancer Clinical Trial More Information about Breast Cancer To find out more about cancer and breast cancer, please visit the websites listed below. National Cancer Institute (NCI) website NCI Educational Material on Clinical Trials: NCI Dictionary of Cancer Terminology: